Patients with blood cancer precursor at risk of developing cancer even after 30 years
Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer—even after 30 years of stability. These are the findings of a study by Mayo Clinic researchers ...
Jan 17, 2018
0
3